A Comparative Retrospective Study Between Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Psoriasis
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Enrollment
- 100
- Primary Endpoint
- The Holmes and Rahe stress scale
- Last Updated
- 9 years ago
Overview
Brief Summary
The aim of this study is to evaluate the psychological impact of psoriasis or hidradenitis suppurativa on patients, in order to compare both pathologies.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Men and women at least 18 years old at the time of selection.
- •Subjects diagnosed with psoriasis or hidradenitis suppurativa
- •Subjects who had completed the questionnaires for psychological impact.
- •Patients should be able to understand and communicate with the investigator.
Exclusion Criteria
- •Subjects suffering from a serious concomitant illness.
- •Subjects with a mental illness.
- •Subjects who are performing psychiatric treatment.
- •Patients who have alcohol dependence or drug abuse.
- •Subjects that present legal incapacity or limited legal capacity.
- •Subjects presenting illiteracy or language barriers.
Outcomes
Primary Outcomes
The Holmes and Rahe stress scale
Time Frame: 1 day
The Holmes and Rahe stress scale is a list of 43 stressful life events that can contribute to illness.
Perceived Stress Scale (PSS)
Time Frame: 1 day
Perceived Stress Scale (PSS) was originally developed by Cohen (1983) and this scale is a self-report instrument that evaluates the level of stress perceived during the last month. The scale consists of 14 items with a response format of a five-point scale (0 = never, 1 = almost never, 2 = Every now and then, 3 = often, 4 = very often). The score obtained indicates that a higher score corresponds to a higher level of perceived stress.
Dermatology Quality of Life Index (DLQI)
Time Frame: 1 day
The Dermatology Life Quality Index or DLQI, developed in 1994, was the first dermatology-specific Quality of Life instrument. It is a simple 10-question validated questionnaire that has been used in over 40 different skin conditions in over 80 countries and is available in over 90 languages. Its use has been described in over 1000 publications including many multinational studies. The DLQI is the most frequently used instrument in studies of randomised controlled trials in dermatology.
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 1 day
Hospital Anxiety and Depression Scale (HADS) was originally developed by Zigmond and Snaith (1983) and is commonly used by doctors to determine the levels of anxiety and depression that a patient is experiencing. The HADS is a fourteen item scale that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression.
Secondary Outcomes
- Static Physician's Global Assessment (sPGA)(1 day)
- Psoriasis Area Severity Index (PASI)(1 day)
- Hurley's staging system(1 day)
- Hidradenitis Suppurativa - Physician Global Assessment (HS-PGA)(1 day)